CLAIRE BOOMHOWER: Open Payments
NPI 1386311876 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 32 payments from 11 companies in 2025. Trend: 2023 $316 · 2024 $913 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $163 |
| Novartis Pharmaceuticals Corporation | 8 | $135 |
| HEARTFLOW, INC. | 4 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| SCPHARMACEUTICALS INC. | 2 | $45 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $26 |
| Boston Scientific Corporation | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
Products named: ELIQUIS, LEQVIO, FFRct, JARDIANCE, FUROSCIX, INSPIRE, Wegovy, WATCHMAN FLX.
Industry payments across TX — which companies pay providers there.
